The company Investigator Studies Program (MISP) aims to advance science and improve patient care by supporting, through the provision of drug/vaccine and/or total/partial funding, high-quality research that is initiated, designed, implemented, and sponsored by external investigators. Results will be generated and properly disseminated in peer-reviewed publications.